[Pharmacological basis of the symptomatic treatment of arterial hypertension. I. Hemodynamic effects, mechanisms of action and side effects of antihypertensive agents].
D000804:Angiotensin II; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003000:Clonidine / Q000009:adverse effects / Q000627:therapeutic use; D003981:Diazoxide / Q000009:adverse effects / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000009:adverse effects / Q000627:therapeutic use; D006145:Guanethidine / Q000009:adverse effects / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008134:Long-Term Care; D008526:Medulla Oblongata / Q000187:drug effects; D008750:Methyldopa / Q000009:adverse effects / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011941:Receptors, Adrenergic / Q000187:drug effects*; D012083:Renin; D012110:Reserpine / Q000009:adverse effects / Q000627:therapeutic use; D009435:Synaptic Transmission / Q000187:drug effects; D014666:Vasomotor System / Q000187:drug effects*
D000959:Antihypertensive Agents; D004232:Diuretics; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D011941:Receptors, Adrenergic; D000804:Angiotensin II; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D011433:Propranolol; D012083:Renin; D003000:Clonidine; D003981:Diazoxide; D006145:Guanethidine
Bases pharmacologiques du traitement symptomatique de l'hypertension artérielle. I. Effts hémodynamiques, mécanismes d'action et effets secondaires des anti-hypertenseurs.